Even though actuaries have advocated for having a standardised rate for COVID-19 procedures, they feel that the same must be reviewed from time to time. “I think this is a welcome step given the COVID-19 is a new illness with no established protocols and standardised treatment. This standard rate will bring in certainly among patients and also will be an important input for pricing. In addition to that it would also bring clarity and transparency in the treatment of COVID-19,” says Gopal V Kumar, Actuary & Economist, Radgo & Company. The premia, as per Sanjay Datta, Chief, Underwriting and Claims, ICICI Lombard, have already gone up by 5 to 7 per cent as of now.